Challenges in Accessing Monkeypox Treatment for High-Risk Populations

In mid-June, cases of monkeypox were in the double digits in the United States. There were drug treatments and vaccines against it. There didn’t seem to be any reason for alarm.

But in the weeks since, the virus has spread rapidly across the country, with some local and state officials declaring public health emergencies.

Guest: Apoorva Mandavilli, a science and global health reporter for The New York Times.

Want more from The Daily? For one big idea on the news each week from our team, subscribe to our newsletter. 

Background reading: 

• Longstanding weaknesses in the American public health system are giving monkeypox a chance to become entrenched.
• Here are answers to three pressing questions about how the virus spreads and how it can be treated.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.